Aidoc, a provider of healthcare AI solutions, has secured $110 million in Series D funding, bringing its total funding to $250 million. The investment, led by TCV and Alpha Intelligence Capital, will be used to expand Aidoc’s AI Care Platform. The platform is designed to help hospitals manage patient care, from diagnosis to treatment and follow-up.
Having undergone clinical research, the Aidoc platform has the potential to help reduce patients’ time to treatment, shorten their stay in the emergency department and enable physicians to capture more patients in need of advanced treatments. The technology features 15 FDA-cleared clinical solutions and a care coordination application. It is intended to help physicians manage patient care and make decisions based on data.
“... With this new round of investment, our aim is to massively ramp up our AI Care Platform to cover both the various hospital medical service lines and the depth of integration into the clinical workflows, empowering hospitals to activate cross-specialty care teams and deliver the best quality of care in a scalable, efficient way to patients,” Elad Walach, Aidoc’s CEO, said in a statement.
